Drug Report History #15753
Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that have changed between versions will be highlighted in yellow, and the changes will be clearly marked as updated.
The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow, and the change will be clearly marked as updated.
| Field | Version v35-FR | Version v25-FR |
|---|---|---|
| Language | French | French |
| Date Updated | 2018-07-30 (Updated) | 2017-08-10 |
| Drug Identification Number | 02407833 | 02407833 |
| Brand name | TRISENOX | TRISENOX |
| Common or Proper name | Arsenic Trioxide for Injection | Arsenic Trioxide for Injection |
| Company Name | LUNDBECK CANADA INC | LUNDBECK CANADA INC |
| Ingredients | ARSENIC TRIOXIDE | ARSENIC TRIOXIDE |
| Strength(s) | 1MG | 1MG |
| Dosage form(s) | SOLUTION | SOLUTION |
| Route of administration | INTRAVENOUS | INTRAVENOUS |
| Packaging size | 10 mg/10mL ampoule | 10 mg/10mL ampoule |
| ATC code | L01XX | L01XX |
| ATC description | OTHER ANTINEOPLASTIC AGENTS | OTHER ANTINEOPLASTIC AGENTS |
| Reason for shortage | Disruption of the manufacture of the drug. | Disruption of the manufacture of the drug. |
| Anticipated start date | 2017-09-08 (Updated) | 2017-09-13 |
| Actual start date | 2017-09-08 (Updated) | |
| Estimated end date | 2018-07-20 (Updated) | 2017-12-31 |
| Actual end date | 2018-07-24 (Updated) | |
| Shortage status | Resolved (Updated) | Anticipated shortage |
| Tier 3 Status | No | No |
| Company comments | ||
| Health Canada comments |